Related Experiment Video
Updated: Jan 30, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Serum 25-Hydroxyvitamin D Concentrations at Birth in Children Screened for HLA-DQB1 Conferred Risk for Type 1
Marjaana Mäkinen1,2, Eliisa Löyttyniemi3, Maarit Koskinen1,2
1MediCity, University of Turku, Turku, Finland.
Insights
Vitamin D levels at birth do not predict type 1 diabetes (T1D) or islet autoimmunity (IA) development in children. This study found no significant difference in cord blood 25-hydroxy-vitamin D (25[OH]D) concentrations between children who developed T1D/IA and those who did not.
Area of Science:
- Immunology
- Endocrinology
- Pediatrics
Background:
- Vitamin D influences the immune system, potentially affecting type 1 diabetes (T1D) pathogenesis.
- Investigating vitamin D's role in T1D is crucial for understanding disease development.
Purpose of the Study:
- To determine if umbilical cord serum 25-hydroxy-vitamin D (25[OH]D) concentrations differ in children who develop islet autoimmunity (IA) or T1D.
- To assess the association between neonatal vitamin D status and the subsequent development of T1D or IA.
Main Methods:
- Analyzed umbilical cord serum samples from 764 children at high risk for T1D.
- Measured 25(OH)D levels using enzyme immunoassay in children who developed T1D, IA, or remained autoantibody-negative controls.
- Followed participants for a median of 9.8 years.
Main Results:
- Median cord serum 25(OH)D concentration was low (31.1 nmol/L), with 88% below 50 nmol/L.
- No statistically significant difference in 25(OH)D levels was observed between children who developed T1D or IA and their matched controls (P=0.70).
- 25(OH)D levels were associated with geographical location, birth timing, maternal age, and vitamin D intake during pregnancy.
Conclusions:
- Neonatal 25-hydroxy-vitamin D concentrations are not associated with the development of type 1 diabetes in childhood.
- Vitamin D status at birth does not appear to be a predictive factor for T1D or IA.
Context:
Vitamin D has several effects on the immune system that might be of relevance for the pathogenesis of type 1 diabetes (T1D).
Objective:
To evaluate whether umbilical cord serum concentrations of 25-hydroxy-vitamin D (25[OH]D) differ in children developing either islet autoimmunity (IA) or overt T1D during childhood and adolescence.
Design:
Umbilical cord serum samples from 764 children born from 1994 to 2004 with HLA-DQB1 conferred risk for T1D participating in the Type 1 Diabetes Prediction and Prevention Study were analyzed for 25(OH)D using an enzyme immunoassay.
Setting:
DIPP clinics in Turku, Oulu, and Tampere University Hospitals, Finland.
Participants:
Two hundred fifty children who developed T1D diabetes at a median age of 6.7 years (interquartile range [IQR] 4.0 to 10.1 years) and 132 additional case children who developed IA, i.e., positivity for multiple islet autoantibodies. Cases were matched for date of birth, gender, and area of birth with 382 control children who remained autoantibody negative. The median duration of follow up was 9.8 years (IQR 5.7 to 13.1 years).
Main Outcome Measure:
The median 25(OH)D concentrations.
Results:
The median 25(OH)D concentration in cord serum was low [31.1 nmol/L (IQR 24.0 to 41.8); 88% <50 nmol/L], but not statistically different between children who developed T1D or IA and their control groups (P = 0.70). The levels were associated mainly with geographical location, year and month of birth, age of the mother, and maternal intake of vitamin D during pregnancy.
Conclusions:
The 25(OH)D concentrations at birth are not associated with the development of T1D during childhood.
More Related Videos
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
14:43A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Birth Control Methods
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
Relative Risk
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration